Authors:
SPIVAK CE
BEGLAN CL
SEIDLECK BK
HIRSHBEIN LD
BLASCHAK CJ
UHL GR
SURRATT CK
Citation: Ce. Spivak et al., NALOXONE ACTIVATION OF MU-OPIOID RECEPTORS MUTATED AT A HISTIDINE RESIDUE LINING THE OPIOID BINDING CAVITY, Molecular pharmacology, 52(6), 1997, pp. 983-992
Citation: Ce. Spivak, CORRELATIONS AMONG HILL PARAMETERS REFLECT MODELS OF ACTIVATING LIGAND-GATED ION CHANNELS, Trends in pharmacological sciences, 16(2), 1995, pp. 39-42
Citation: Ce. Spivak, DESENSITIZATION AND NONCOMPETITIVE BLOCKADE OF GABA(A) RECEPTORS IN VENTRAL MIDBRAIN NEURONS BY A NEUROSTEROID DEHYDROEPIANDROSTERONE-SULFATE, Synapse, 16(2), 1994, pp. 113-122
Authors:
WANG JB
IMAI YS
EPPLER CM
GREGOR P
SPIVAK CE
UHL GR
Citation: Jb. Wang et al., MU-OPIATE RECEPTOR - CDNA CLONING AND EXPRESSION, Proceedings of the National Academy of Sciences of the United Statesof America, 90(21), 1993, pp. 10230-10234
Authors:
KUSAMA T
SPIVAK CE
WHITING P
DAWSON VL
SCHAEFFER JC
UHL GR
Citation: T. Kusama et al., PHARMACOLOGY OF GABA RHO-1 AND GABA ALPHA BETA RECEPTORS EXPRESSED INXENOPUS OOCYTES AND COS CELLS/, British Journal of Pharmacology, 109(1), 1993, pp. 200-206